0002022176-24-000002.txt : 20240507
0002022176-24-000002.hdr.sgml : 20240507
20240507140314
ACCESSION NUMBER: 0002022176-24-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240507
DATE AS OF CHANGE: 20240507
EFFECTIVENESS DATE: 20240507
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atacama Therapeutics, Inc.
CENTRAL INDEX KEY: 0002022176
ORGANIZATION NAME:
IRS NUMBER: 814057067
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-512480
FILM NUMBER: 24921104
BUSINESS ADDRESS:
STREET 1: 65 WILLIAM STREET
STREET 2: SUITE 200
CITY: WELLESLEY
STATE: MA
ZIP: 02481
BUSINESS PHONE: 617-225-7700
MAIL ADDRESS:
STREET 1: 65 WILLIAM STREET
STREET 2: SUITE 200
CITY: WELLESLEY
STATE: MA
ZIP: 02481
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0002022176
Atacama Therapeutics, Inc.
65 WILLIAM STREET
SUITE 200
WELLESLEY
MA
MASSACHUSETTS
02481
617-225-7700
DELAWARE
None
None
Corporation
true
Joseph
Baron
c/o Atacama Therapeutics, Inc.
65 William Street, Suite 200
Wellesley
MA
MASSACHUSETTS
02481
Executive Officer
Director
Jonathan
Reis
c/o Atacama Therapeutics, Inc.
65 William Street, Suite 200
Wellesley
MA
MASSACHUSETTS
02481
Director
Other Health Care
Decline to Disclose
- 06b
true
0002022176-24-000001
2024-04-26
false
true
false
2500
4725000
830000
3895000
false
16
0
0
0
false
Atacama Therapeutics, Inc.
/s/Joseph Baron
Joseph Baron
Chief Executive Officer
2024-05-07